Skip to main content
Log in

Liver stiffness measured by magnetic resonance elastography as a risk factor for hepatocellular carcinoma: a preliminary case–control study

  • Gastrointestinal
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objective

To examine if liver stiffness measured by magnetic resonance elastography (MRE) is a risk factor for hepatocellular carcinoma (HCC) in patients with chronic liver disease.

Methods

By reviewing the records of magnetic resonance (MR) examinations performed at our institution, we selected 301 patients with chronic liver disease who did not have a previous medical history of HCC. All patients underwent MRE and gadoxetic acid-enhanced MR imaging. HCC was identified on MR images in 66 of the 301 patients, who were matched to controls from the remaining patients without HCC according to age. MRE images were obtained by visualising elastic waves generated in the liver by pneumatic vibration transferred via a cylindrical passive driver. Risk factors of HCC development were determined by the odds ratio with logistic regression analysis; gender and liver stiffness by MRE and serum levels of aspartate transferase, alanine transferase, alpha-fetoprotein, and protein induced by vitamin K absence-II.

Results

Multivariate analysis revealed that only liver stiffness by MRE was a significant risk factor for HCC with an odds ratio (95 % confidence interval) of 1.38 (1.05–1.84).

Conclusion

Liver stiffness measured by MRE is an independent risk factor for HCC in patients with chronic liver disease.

Key Points

Magnetic resonance elastography can estimate liver stiffness, a marker of hepatic fibrosis.

Liver stiffness is an independent risk factor of hepatocellular carcinoma (HCC).

Liver stiffness seems a better indicator of HCC than tumour markers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Sakamoto M, Hirohashi S, Shimosato Y (1991) Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol 22:172–178

    Article  PubMed  CAS  Google Scholar 

  2. Yoshida H, Shiratori Y, Moriyama M et al (1999) Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy. Ann Intern Med 131:174–181

    PubMed  CAS  Google Scholar 

  3. Tsochatzis EA, Gurusamy KS, Ntaoula S, Cholongitas E, Davidson BR, Burroughs AK (2011) Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. J Hepatol 54:650–659

    Article  PubMed  CAS  Google Scholar 

  4. Yin M, Talwalkar JA, Glaser KJ et al (2007) Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol 5:e1202

    Article  Google Scholar 

  5. Rouviere O, Yin M, Dresner MA et al (2006) MR elastography of the liver: preliminary results. Radiology 240:440–448

    Article  PubMed  Google Scholar 

  6. Motosugi U, Ichikawa T, Sou H et al (2010) Magnetic resonance elastography of the liver: preliminary results and estimation of interrater reliability. Jpn J Radiol 28:623–627

    Article  PubMed  Google Scholar 

  7. Asbach P, Klatt D, Schlosser B et al (2010) Viscoelasticity-based staging of hepatic fibrosis with multifrequency MR elastography. Radiology 257:80–86

    Article  PubMed  Google Scholar 

  8. Huwart L, Sempoux C, Salameh N et al (2007) Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index. Radiology 245:458–466

    Article  PubMed  Google Scholar 

  9. Klatt D, Asbach P, Rump J et al (2006) In vivo determination of hepatic stiffness using steady-state free precession magnetic resonance elastography. Invest Radiol 41:841–848

    Article  PubMed  Google Scholar 

  10. Masuzaki R, Tateishi R, Yoshida H et al (2009) Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography. Hepatology 49:1954–1961

    Article  PubMed  Google Scholar 

  11. Tanimoto A, Lee JM, Murakami T, Huppertz A, Kudo M, Grazioli L (2009) Consensus report of the 2nd International Forum for Liver MRI. Eur Radiol 19:S975–S989

    Article  PubMed  Google Scholar 

  12. Bruix J, Sherman M (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020–1022

    Article  PubMed  Google Scholar 

  13. Addley HC, Griffin N, Shaw AS et al (2011) Accuracy of hepatocellular carcinoma detection on multidetector CT in a transplant liver population with explant liver correlation. Clin Radiol 66:349–356

    Article  PubMed  CAS  Google Scholar 

  14. Ichikawa T, Erturk SM, Araki T (2006) Multiphasic contrast-enhanced multidetector-row CT of liver: contrast-enhancement theory and practical scan protocol with a combination of fixed injection duration and patients' body-weight-tailored dose of contrast material. Eur J Radiol 58:165–176

    Article  PubMed  Google Scholar 

  15. Mannelli L, Godfrey E, Joubert I et al (2010) MR elastography: spleen stiffness measurements in healthy volunteers–preliminary experience. AJR Am J Roentgenol 195:387–392

    Article  PubMed  Google Scholar 

  16. Manduca A, Oliphant TE, Dresner MA et al (2001) Magnetic resonance elastography: non-invasive mapping of tissue elasticity. Med Image Anal 5:237–254

    Article  PubMed  CAS  Google Scholar 

  17. Huwart L, Sempoux C, Vicaut E et al (2008) Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology 135:32–40

    Article  PubMed  Google Scholar 

  18. Hines CD, Bley TA, Lindstrom MJ, Reeder SB (2010) Repeatability of magnetic resonance elastography for quantification of hepatic stiffness. J Magn Reson Imaging 31:725–731

    Article  PubMed  Google Scholar 

  19. Hines CD, Lindstrom MJ, Varma AK, Reeder SB (2011) Effects of postprandial state and mesenteric blood flow on the repeatability of MR elastography in asymptomatic subjects. J Magn Reson Imaging 33:239–244

    Google Scholar 

  20. Shire NJ, Yin M, Chen J et al (2011) Test-retest repeatability of MR elastography for noninvasive liver fibrosis assessment in hepatitis C. J Magn Reson Imaging 34:947–955

    Article  PubMed  Google Scholar 

  21. Inoue A, Tsukuma H, Oshima A et al (2000) Effectiveness of interferon therapy for reducing the incidence of hepatocellular carcinoma among patients with type C chronic hepatitis. J Epidemiol 10:234–240

    Article  PubMed  CAS  Google Scholar 

  22. Ikeda K, Saitoh S, Koida I et al (1993) A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 18:47–53

    Article  PubMed  CAS  Google Scholar 

  23. Ikeda K, Saitoh S, Suzuki Y et al (1998) Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients. J Hepatol 28:930–938

    Article  PubMed  CAS  Google Scholar 

  24. Ohki T, Tateishi R, Sato T et al (2008) Obesity is an independent risk factor for hepatocellular carcinoma development in chronic hepatitis C patients. Clin Gastroenterol Hepatol 6:459–464

    Article  PubMed  Google Scholar 

  25. Kiyosawa K, Umemura T, Ichijo T et al (2004) Hepatocellular carcinoma: recent trends in Japan. Gastroenterology 127:S17–S26

    Article  PubMed  Google Scholar 

  26. El-Serag HB (2004) Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 127:S27–S34

    Article  PubMed  Google Scholar 

  27. Masuzaki R, Tateishi R, Yoshida H et al (2008) Risk assessment of hepatocellular carcinoma in chronic hepatitis C patients by transient elastography. J Clin Gastroenterol 42:839–843

    Article  PubMed  Google Scholar 

  28. Anaparthy R, Talwalkar JA, Yin M, Roberts LR, Fidler JL, Ehman RL (2011) Liver stiffness measurement by magnetic resonance elastography is not associated with developing hepatocellular carcinoma in subjects with compensated cirrhosis. Aliment Pharmacol Ther 34:83–91

    Article  PubMed  CAS  Google Scholar 

  29. The Liver Cancer Study Group of Japan (2009) Clinical guideline of liver cancer. Kanehara, Tokyo

    Google Scholar 

  30. Kogita S, Imai Y, Okada M et al (2010) Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow. Eur Radiol 20:2405–2413

    Article  PubMed  Google Scholar 

  31. Sano K, Ichikawa T, Motosugi U et al (2011) Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced magnetic resonance imaging. Radiology 261:834–844

    Article  PubMed  Google Scholar 

  32. Rhee H, Kim MJ, Park YN, Choi JS, Kim KS (2012) Gadoxetic acid-enhanced MRI findings of early hepatocellular carcinoma as defined by new histologic criteria. J Magn Reson Imaging 35:393–398

    Article  PubMed  Google Scholar 

  33. Golfieri R, Renzulli M, Lucidi V, Corcioni B, Trevisani F, Bolondi L (2011) Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to dynamic MRI in the detection of hypovascular small (≤2 cm) HCC in cirrhosis. Eur Radiol 21:1233–1242

    Article  PubMed  Google Scholar 

  34. Chen J, Talwalkar JA, Yin M, Glaser KJ, Sanderson SO, Ehman RL (2011) Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology 259:749–756

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

We thank Richard Ehman and Scott Kruse from the Mayo Clinic, and Tetsuya Wakayama from GE Healthcare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Utaroh Motosugi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Motosugi, U., Ichikawa, T., Koshiishi, T. et al. Liver stiffness measured by magnetic resonance elastography as a risk factor for hepatocellular carcinoma: a preliminary case–control study. Eur Radiol 23, 156–162 (2013). https://doi.org/10.1007/s00330-012-2571-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-012-2571-6

Keywords

Navigation